READ OUR
LATEST NEWS
Featured
OUR FEATURED NEWS
Featured
A donation of $1,601,830 to support the Vera Bradley Foundation Center for Breast Cancer Research at the IU School of Medicine was announced today. With this gift, the Foundation has funded $41.7 million of breast cancer research to date.
Mary Ellen is a breast cancer survivor and a committed Foundation volunteer. Finding that she was often asked for advice from newly diagnosed friends, Mary Ellen crafted a comprehensive email filled with advice and tips that can be easily shared
Chemotherapy type can be personalized to decrease harmful side effects for Black patients with breast cancer . Researchers at the Vera Bradley Foundation Center for Breast Cancer Research at the IU School of Medicine have discovered that Black patients with breast cancer who are treated with a chemotherapy called docetaxel experience less of a harmful side effect called peripheral neuropathy.
Breast cancer diagnoses bring about all kinds of questions. With so many changes and challenges, navigating a new normal can be overwhelming. Nothing calms anxiety quite like hearing answers directly from an oncologist. Luckily, we know a great one!
Anna Maria Storniolo, MD, a specialist in breast care and cancer treatment, now serves on the Vera Bradley Foundation for Breast Cancer Board of Directors. An oncologist and clinical researcher for over 40 years, she was an active participant in bringing science to the bedside and clinical observations back to the laboratory. With over 140 publications, Dr. Storniolo’s work has impacted women – and the research world – forever!
The research team at the Vera Bradley Foundation Center for Breast Cancer Research includes 37 breast cancer researchers who have a diverse array of skills.
A donation of $1,513,713 to support the Vera Bradley Foundation Center for Breast Cancer Research at the IU School of Medicine was announced today. With this gift, the Foundation has funded $40.1 million of breast cancer research to date.
The Vera Bradley Foundation for Breast Cancer started with friendship. Mary Sloan, a longtime friend of Vera Bradley co-founders Barbara Bradley Baekgaard and Patricia Miller, joined them as one of company’s first sales representatives when the company was founded in 1987.
IU School of Medicine researcher develops non-invasive tool to detect mutations that could potentially lead to breast cancer
With breast cancer affecting 1 in 8 women, chances are you already know, or can anticipate knowing, someone who will be diagnosed with breast cancer. Based on my personal experience, here are some of the best ways to help a loved one.
Researchers at Indiana University School of Medicine are learning more about ways to prevent serious side effects from chemotherapy used to treat breast cancer patients.
What a year it has been! Stepping into the role of Executive Director for this amazing organization has been a privilege and blessing. When I reflect on the events of the past year, it is readily apparent that, “Hope lives here.”
Hearing the words, “you have breast cancer” is completely overwhelming, but know you’re not alone. Here are a few things that will make your treatment journey more manageable:
With this donation, the Foundation has provided $38.6 million of funding to breast cancer research since 2000.
The Vera Bradley Foundation for Breast Cancer today announced, after a national search, it has named Stephanie Scheele as its new Executive Director.
Cancer researchers like Kelvin Lee, MD, don’t casually toss around the word “cure.” While cures are universally sought, they aren’t easily found. Unexpected twists and turns are part of the pursuit.
We want to take a moment to celebrate those who have battled this disease with such courage and strength.
Hear from some incredible members of our research team as they discuss immunotherapy treatment and the promising possibilities for breast cancer patients.
Here at the Foundation, we work for all mothers, daughters, sisters, wives, roommates, and friends. We are working for a future where women can live long, fulfilling lives past their diagnoses.
Vera Bradley Foundation for Breast Cancer Makes $12.5 Million Commitment to Indiana University School of Medicine
We are pleased to announce that Mateusz Opyrchal, MD, PhD, began the New Year with a new job as the inaugural Vera Bradley Foundation Scholar in Breast Cancer Discovery in the Vera Bradley Foundation Center for Breast Cancer Research.
From the day of her diagnosis, a woman becomes a breast cancer survivor forever. Research in the Vera Bradley Foundation Center for Breast Cancer Research is empowering each survivor to live her life with strength and resiliency.
From the day of her diagnosis, a woman becomes a breast cancer survivor forever. Research in the Vera Bradley Foundation Center for Breast Cancer Research is empowering each survivor to live her life with strength and resiliency.
Researchers from Indiana University School of Medicine are discovering new ways to find out how effective a drug might be against cancer. Their findings are detailed in a new paper published by Science Advances.
Stephanie Pemberton was diagnosed with breast cancer in February 2020 and underwent treatment involving 16 weeks of chemotherapy and a double mastectomy.
It’s common for people to ask friends to donate to a favorite charitable cause in lieu of birthday gifts, but Charlene Cheatham is taking it a step further. She’s asking her friends to donate their breast tissue.
Researchers in the Vera Bradley Foundation Center for Breast Cancer Research continue to improve the cure rate for women with the highest risk for recurrence of TNBC. Research builds on the highly successful Monogrammed Medicine program to develop better, more personalized therapies.
Indiana University School of Medicine scientists continue search for life-saving treatments for aggressive types of breast cancer.
Jenny is a five-year stage 4 triple negative and inflammatory breast cancer survivor who recorded her story in 2019 with the Indiana University School of Medicine.
Vera Bradley Foundation Center researchers, Kathy D. Miller, MD, and Hari Nakshatri, PHD, on “Breast Cancer and Black Women: Research to Reduce Disparities.”
Jenny is a five-year triple negative breast cancer survivor. She’s been in complete remission since participating in the two-drug trial targeting TNBC’s most active genes. Her oncologist, Kathy Miller, MD, led the trial, and Jenny is alive today because of this Vera Bradley Foundation-funded research conducted by the Monogrammed Medicine team.